171 related articles for article (PubMed ID: 31745134)
1. Characteristics of Patent Ductus Arteriosus in Congenital Rubella Syndrome.
Toizumi M; Do CGT; Motomura H; Do TN; Fukunaga H; Iijima M; Le NN; Nguyen HT; Moriuchi H; Yoshida LM
Sci Rep; 2019 Nov; 9(1):17105. PubMed ID: 31745134
[TBL] [Abstract][Full Text] [Related]
2. An update on cardiovascular malformations in congenital rubella syndrome.
Oster ME; Riehle-Colarusso T; Correa A
Birth Defects Res A Clin Mol Teratol; 2010 Jan; 88(1):1-8. PubMed ID: 19697432
[TBL] [Abstract][Full Text] [Related]
3. [Transcatheter occlusion of patent ductus arteriosus in a preterm infant and review of literatures].
Zhou K; Tang J; Hua Y; Shi X; Wang Y; Qiao L; Wang X; Mu D
Zhonghua Er Ke Za Zhi; 2016 Jan; 54(1):43-6. PubMed ID: 26791923
[TBL] [Abstract][Full Text] [Related]
4. A Retrospective Study of 1,526 Cases of Transcatheter Occlusion of Patent Ductus Arteriosus.
Jin M; Liang YM; Wang XF; Guo BJ; Zheng K; Gu Y; Lyu ZY
Chin Med J (Engl); 2015 Sep; 128(17):2284-9. PubMed ID: 26315073
[TBL] [Abstract][Full Text] [Related]
5. Transcatheter Closure of Patent Ductus Arteriosus in Children with the Occlutech Duct Occluder.
Bilici M; Demir F; Akın A; Türe M; Balık H; Kuyumcu M
Pediatr Cardiol; 2017 Dec; 38(8):1598-1605. PubMed ID: 28828684
[TBL] [Abstract][Full Text] [Related]
6. Closure of very large PDA with pulmonary hypertension: Initial clinical case-series with the new Occlutech
Lehner A; Ulrich S; Happel CM; Fischer M; Kantzis M; Schulze-Neick I; Haas NA
Catheter Cardiovasc Interv; 2017 Mar; 89(4):718-725. PubMed ID: 27860161
[TBL] [Abstract][Full Text] [Related]
7. Transcatheter occlusion of the patent ductus arteriosus in premature infants weighing less than 1200 g.
Morville P; Douchin S; Bouvaist H; Dauphin C
Arch Dis Child Fetal Neonatal Ed; 2018 May; 103(3):F198-F201. PubMed ID: 29066474
[TBL] [Abstract][Full Text] [Related]
8. [Transcatheter closure of patent ductus arteriosus using the Amplatzer duct occluder in children: initial and one-year results].
Parra-Bravo JR; Cruz-Ramírez A; Toxqui-Terán A; Juan-Martínez E; Chávez-Fernández AA; Lazo-Cárdenas C; Beirana-Palencia L; Estrada-Flores J
Arch Cardiol Mex; 2009; 79(2):114-20. PubMed ID: 19722381
[TBL] [Abstract][Full Text] [Related]
9. Transcatheter Patent Ductus Arteriosus Occlusion in Small Infants.
Schwartz MC; Nykanen D; Winner LH; Perez J; McMahan M; Munro HM; Suguna Narasimhulu S
Congenit Heart Dis; 2016 Dec; 11(6):647-655. PubMed ID: 27225896
[TBL] [Abstract][Full Text] [Related]
10. The new Occlutech(®) patent ductus arteriosus occluder: Single centre experience.
Boudjemline Y
Arch Cardiovasc Dis; 2016; 109(6-7):384-9. PubMed ID: 26988839
[TBL] [Abstract][Full Text] [Related]
11. Is the new Occlutech duct occluder an appropriate device for transcatheter closure of patent ductus arteriosus?
Godart F; Houeijeh A; Domanski O; Guillaume MP; Brard M; Lucron H
Int J Cardiol; 2018 Jun; 261():54-57. PubMed ID: 29551254
[TBL] [Abstract][Full Text] [Related]
12. Transcatheter closure of patent ductus arteriosus: 11 years of clinical experience in Cipto Mangunkusumo Hospital, Jakarta, Indonesia.
Djer MM; Saputro DD; Putra ST; Idris NS
Pediatr Cardiol; 2015 Jun; 36(5):1070-4. PubMed ID: 25749918
[TBL] [Abstract][Full Text] [Related]
13. Transcatheter closure of hemodynamic significant patent ductus arteriosus in 32 premature infants by amplatzer ductal occluder additional size-ADOIIAS.
Morville P; Akhavi A
Catheter Cardiovasc Interv; 2017 Oct; 90(4):612-617. PubMed ID: 28471089
[TBL] [Abstract][Full Text] [Related]
14. Morphologic characterization of the patent ductus arteriosus in the premature infant and the choice of transcatheter occlusion device.
Philip R; Waller BR; Agrawal V; Wright D; Arevalo A; Zurakowski D; Sathanandam S
Catheter Cardiovasc Interv; 2016 Feb; 87(2):310-7. PubMed ID: 26525611
[TBL] [Abstract][Full Text] [Related]
15. Mortality associated with pulmonary hypertension in congenital rubella syndrome.
Toizumi M; Motomura H; Vo HM; Takahashi K; Pham E; Nguyen HA; Le TH; Hashizume M; Ariyoshi K; Dang DA; Moriuchi H; Yoshida LM
Pediatrics; 2014 Aug; 134(2):e519-26. PubMed ID: 25002666
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous closure of patent ductus arteriosus in children using amplatzer duct occluder II: relationship between PDA type and risk of device protrusion into the descending aorta.
Masri S; El Rassi I; Arabi M; Tabbakh A; Bitar F
Catheter Cardiovasc Interv; 2015 Aug; 86(2):E66-72. PubMed ID: 26032159
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous device closure of patent ductus arteriosus with pulmonary artery hypertension: long-term results.
Vijayalakshmi IB; Setty N; Narasimhan C; Singla V; Manjunath CN
J Interv Cardiol; 2014 Dec; 27(6):563-9. PubMed ID: 25490863
[TBL] [Abstract][Full Text] [Related]
18. Use of the amplatzer vascular plug II device to occlude different types of patent ductus arteriosus in pediatric patients.
Garay FJ; Aguirre D; Cárdenas L; Springmuller D; Heusser F
J Interv Cardiol; 2015 Apr; 28(2):198-204. PubMed ID: 25832322
[TBL] [Abstract][Full Text] [Related]
19. Severe Pulmonary Arteriopathy in a Neonate with Congenital Rubella Syndrome and Patent Ductus Arteriosus.
Khurana S; Bansal A; Saini SS; Mishra A; Kumar P
Indian Pediatr; 2019 Oct; 56(10):868-872. PubMed ID: 31724543
[TBL] [Abstract][Full Text] [Related]
20. Short-term results of interventional therapy for infants (7-36 months old) with patent ductus arteriosus and moderate-to-severe pulmonary hypertension: a retrospective study.
Shu Y; Guo Y; Wang X; Zhou D
J Cardiothorac Surg; 2020 Apr; 15(1):68. PubMed ID: 32321548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
